Data from studies in animal models indicate that certain lipid metabolites, particularly diacylglycerol, ceramide, and acylcarnitine, disrupt insulin action. We evaluated the relationship between the presence of these metabolites in the liver (assessed by mass spectrometry) and hepatic insulin sensitivity (assessed using a hyperinsulinemic-euglycemic clamp with stable isotope tracer infusion) in 16 obese adults (body mass index, 48 ± 9 kg/m²). There was a negative correlation between insulin-mediated suppression of hepatic glucose production and intrahepatic diacylglycerol (r = -0.609; P = .012), but not with intrahepatic ceramide or acylcarnitine. These data indicate that intrahepatic diacylglycerol is an important mediator of hepatic insulin resistance in obese people with nonalcoholic fatty liver disease.

Magkos, F., Su, X., Bradley, D., Fabbrini, E., Conte, C., Eagon, J., Varela, J., Brunt, E., Patterson, B., Klein, S., Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects, <<GASTROENTEROLOGY>>, 2012; 142 (7): 1444-1444-6.e2. [doi:10.1053/j.gastro.2012.03.003] [http://hdl.handle.net/10807/61326]

Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects

Conte, Caterina;
2012

Abstract

Data from studies in animal models indicate that certain lipid metabolites, particularly diacylglycerol, ceramide, and acylcarnitine, disrupt insulin action. We evaluated the relationship between the presence of these metabolites in the liver (assessed by mass spectrometry) and hepatic insulin sensitivity (assessed using a hyperinsulinemic-euglycemic clamp with stable isotope tracer infusion) in 16 obese adults (body mass index, 48 ± 9 kg/m²). There was a negative correlation between insulin-mediated suppression of hepatic glucose production and intrahepatic diacylglycerol (r = -0.609; P = .012), but not with intrahepatic ceramide or acylcarnitine. These data indicate that intrahepatic diacylglycerol is an important mediator of hepatic insulin resistance in obese people with nonalcoholic fatty liver disease.
2012
Inglese
Magkos, F., Su, X., Bradley, D., Fabbrini, E., Conte, C., Eagon, J., Varela, J., Brunt, E., Patterson, B., Klein, S., Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects, <<GASTROENTEROLOGY>>, 2012; 142 (7): 1444-1444-6.e2. [doi:10.1053/j.gastro.2012.03.003] [http://hdl.handle.net/10807/61326]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/61326
Citazioni
  • ???jsp.display-item.citation.pmc??? 80
  • Scopus 152
  • ???jsp.display-item.citation.isi??? 145
social impact